Drug intelligence / Profile preview

aceclofenac + acetaminophen

Development stage
Unknown
Lead developer
CRIS Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Aceclofenac + acetaminophen (also known as aceclofenac and paracetamol) is an approved oral small molecule combination drug. It combines aceclofenac, a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID), with acetaminophen (paracetamol), a widely used analgesic and antipyretic. Aceclofenac primarily targets and inhibits the cyclooxygenase enzymes COX-1 and COX-2, thereby reducing the production of prostaglandins that mediate pain, swelling, and inflammation. Acetaminophen complements this action through its own analgesic and antipyretic mechanisms, likely involving central COX inhibition and modulation of pain pathways. The combination is indicated for the treatment of pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, musculoskeletal disorders, and dental pain. It is manufactured as a generic formulation by companies including CRIS Pharma.

Other names
aceclofenac + paracetamolaceclofenac and paracetamol tablets
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on aceclofenac + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceclofenac + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call